Oxford Genome Sciences Allies With Amgen on Cancer Therapeutics

Oxford Genome Sciences (OGeS) and Amgen inked an agreement to discover, develop and commercialize therapeutic antibodies for the treatment of cancer.
Genetic Engineering & biotechnology News